A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin (original) (raw)
Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50:7–33 PubMedCAS Google Scholar
Ries LAG, Miller BA, Hankey BF, eds. SEER Cancer Statistics Review: Tables and Graphs_._ Bethesda, MD: National Cancer Institute, 1994 Google Scholar
Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Incidence, treatment and survival in 13,560 patients with pancreatic cancer: an epidemiological study in the West Midlands. Br J Surg 1995; 82:111–5 ArticlePubMedCAS Google Scholar
Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990; 211:447–58 ArticlePubMedCAS Google Scholar
Russell RC. Surgical resection for cancer of the pancreas. Baillieres Clin Gastroenterol 1990; 4:889–916 ArticlePubMedCAS Google Scholar
Gall FP, Kessler H, Hermanek P. Surgical treatment of ductal pancreatic carcinoma. Eur J Surg Oncol 1991; 17:173–81 PubMedCAS Google Scholar
Andren-Sandberg A, Ahren B, Tranberg KG, Bengmark S. Surgical treatment of pancreatic cancer. The Swedish experience. Int J Pancreatol 1991; 9:145–51 PubMedCAS Google Scholar
Edge SB, Schmieg R Jr, Rosenlof LK, Wilhelm MC. Pancreas cancer resection outcome in American university centers in 1989–1990. Cancer 1993; 71:3502–8 ArticlePubMedCAS Google Scholar
Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreatoduodenectomies without mortality. Ann Surg 1993; 217:430–8 ArticlePubMedCAS Google Scholar
Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221:59–66 CAS Google Scholar
Evans DB, Abbruzzese JL, Willett CG. Cancer of the pancreas. In: De Vita, Hellman S, Rosenberg SA, (eds). Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott, Williams and Wilkins, 2001:1126–61
Kaiser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120:899–903 Google Scholar
Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg 1999; 230:776–82 ArticlePubMedCAS Google Scholar
Neoptolemos JP, Stocken DD, Friess H, et al. European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350:1200–10 ArticlePubMedCAS Google Scholar
Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997; 15:928–37 PubMedCAS Google Scholar
Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997; 225:621–33 ArticlePubMedCAS Google Scholar
Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB 3rd. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1998; 16:317–23 PubMedCAS Google Scholar
Breslin TM, Hess KR, Harbison DB, et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 2001; 8:123–32 ArticlePubMedCAS Google Scholar
Brunner TB, Grabenbauer GG, Klein P, et al. Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2003; 55:144–53 ArticlePubMedCAS Google Scholar
Staley CA, Lee JE, Cleary KR, et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996; 171:118–24 ArticlePubMedCAS Google Scholar
Aristu J, Canon R, Pardo F, et al. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol 2003; 26:30–6 ArticlePubMed Google Scholar
Casper ES, Green MR, Kelsen DP, Heelan RT, Brown TD, Flombaum CD. Phase II trial of gemcitabine in patients with adenocarcinoma of the pancreas. Invest New Drugs 1994; 12:29–34 ArticlePubMedCAS Google Scholar
Carmichael J, Fink U, Russell RCG, Spittle MF, Harris A, Spiessl G. Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 1995; 73:101–5 Google Scholar
Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15:2403–13 PubMedCAS Google Scholar
Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ. Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 1996; 2:521–30 PubMedCAS Google Scholar
Crul M, van Waardenburg RC, Bocxe S, et al. DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. Biochem Pharmacol 2003; 65:275–82 ArticlePubMedCAS Google Scholar
Cardenal F, Lopez-Cabrerizo MP, Anton A, et al. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non–small-cell lung cancer. J Clin Oncol 1999; 17:12–8 PubMedCAS Google Scholar
von der Maase H, Hansen SW, Roberts JT, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 18:3068–77 PubMed Google Scholar
Hussain SA, Stocken DD, Riley P, et al. A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer 2004; 91:844–9 PubMedCAS Google Scholar
Heinemann V, Wilke H, Mergenthaler HG, et al. Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer. Ann Oncol 2000; 11(11):1399–403 ArticlePubMedCAS Google Scholar
Philip PA, Zalupski MM, Vaitkevicius VK, et al. Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma. Cancer 2001; 92:569–77 ArticlePubMedCAS Google Scholar
Brodowicz T, Wolfram RM, Kostler WJ, et al. Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer. Anticancer Drugs 2000; 11:623–8 ArticlePubMedCAS Google Scholar
Colucci G, Giuliani F, Gebbia V, et al. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell’Italia Meridionale. Cancer 2002; 94:902–10 ArticlePubMedCAS Google Scholar
Heinemann V, Quietzsch D, Gieseler F, et al. A phase III trial comparing gemcitabine plus cisplatin vs gemcitabine alone in advanced pancreatic carcinoma (abstract 1003). Proc Am Soc Clin Oncol 2003;22
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31–41 ArticlePubMedCAS Google Scholar
Simon R, Wittes RE, Ellenberg SS. Randomized phase II clinical trials. Cancer Treat Rep 1985; 69:1375–81 PubMedCAS Google Scholar
Neuhaus P, Oettle H, Post S, et al. A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs observation in patients with resected pancreatic cancer (abstract 4013). J Clin Oncol, 2005 ASCO Annual Meeting Proceedings 23(16S) Part I of II (June 1 suppl), 2005:4013
Pisters PW, Hudec WA, Lee JE, et al. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. J Clin Oncol 2000; 18:860–7 PubMedCAS Google Scholar
Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991; 161:26–9 ArticlePubMedCAS Google Scholar
Hyoty MK, Mattila JJ, Salo K, Nordback IH. Intraoperative fine needle aspiration cytologic examination of pancreatic lesions. Surg Gynecol Obstet 1991; 173:193–7 PubMedCAS Google Scholar
Jarufe NP, Coldam C, Mayer AD, Mirza DF, Buckels JAC, Bramhall SR. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 2004; 21:202–9 ArticlePubMedCAS Google Scholar
Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 1994; 81:102–7 ArticlePubMedCAS Google Scholar
Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161:120–4 ArticlePubMedCAS Google Scholar
Funovics JM, Karner J, Pratschner T, Fritsch A. Current trends in the management of carcinoma of the pancreatic head. Hepatogastroenterology 1989; 36:450–5 PubMedCAS Google Scholar
Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993; 217:144–8 ArticlePubMedCAS Google Scholar
Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223:718–25 ArticlePubMedCAS Google Scholar